Metabolic Nanomedicine Reprograms Mesenchymal Stem Cells for Durable Exosome‐Mediated Immunomodulation
Exploration · 10.11.2026
DOI: 10.1002/exp2.70249 ↗Kurz gefasst
Fachartikel in der Zeitschrift Exploration, online erschienen am 10.11.2026. Verfasst von Jinfeng Chen und 9 weiteren Autor:innen. Beteiligte Einrichtung: Division of Nanobiomedicine, Suzhou Institute of Nano-Tech and Nano-Bionics (SINANO) Chinese Academy of Sciences Suzhou China. Die Arbeit nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China.
Abstract (Originalsprache)
Mesenchymal stem cells (MSCs) are widely recognized for their immunomodulatory potential, yet their clinical efficacy remains inconsistent due to poor persistence and functional instability under prolonged inflammatory stress. Here we identify NAD + depletion as a central driver of MSCs exhaustion, leading to metabolic collapse, programmed cell death, and loss of immunoregulatory activity. Direct restoration is nontrivial, because NAD + is membrane impermeable and extracellularly unstable. To overcome this barrier, we developed a nanoparticle system for efficient intracellular delivery of NAD + , enabling sustained metabolic support even under hostile inflammatory conditions. NAD + restoration markedly improved MSCs survival, preserved their ability to suppress T cell proliferation, and enhanced therapeutic efficacy in murine colitis. Mechanistically, NAD + supplementation did not increase anti‐inflammatory mediator release but instead reprogrammed exosome function, enhancing secretion and selectively enriching key anti‐inflammatory microRNAs. This effect was mediated by an NAD + /α‐ketoglutarate/TET1‐SMPD3 axis involving promoter demethylation, exosome biogenesis, and microRNA sorting. Together, these findings uncover an epigenetic‐metabolic circuit that links NAD + availability to exosome‐mediated immune regulation, providing a mechanistic foundation for developing metabolically fortified MSCs platforms with enhanced persistence and translational potential in inflammatory disease.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Nanobiomedicine, Suzhou Institute of Nano-Tech and Nano-Bionics (SINANO) Chinese Academy of Sciences Suzhou China.
- Jiangsu Key Laboratory of Organoid Engineering and Precision Medicine Suzhou China.
- University of Science and Technology of China Hefei China.
- Department of Clinical Laboratory Qilu Hospital of Shandong University Jinan China.
Förderung
- National Key Research and Development Program of China
- National Natural Science Foundation of China
Zitieren
APA
Chen, J., Zeng, K., Chao, J., Zhang, X., Zhou, Z., Li, X., Liu, W., Xie, X., Wang, L., & Ye, M. (2026). Metabolic Nanomedicine Reprograms Mesenchymal Stem Cells for Durable Exosome‐Mediated Immunomodulation. Exploration. https://doi.org/10.1002/exp2.70249
Vancouver
Chen J, Zeng K, Chao J, Zhang X, Zhou Z, Li X, et al. Metabolic Nanomedicine Reprograms Mesenchymal Stem Cells for Durable Exosome‐Mediated Immunomodulation. Exploration. 2026. doi:10.1002/exp2.70249
BibTeX
@article{Chen2026,
author = {Chen, Jinfeng and Zeng, Kanghua and Chao, Jinhong and Zhang, Xiangna and Zhou, Zheng and Li, Xiang and Liu, Wancheng and Xie, Xiahong and Wang, Luyao and Ye, Mingzhou},
title = {Metabolic Nanomedicine Reprograms Mesenchymal Stem Cells for Durable Exosome‐Mediated Immunomodulation},
journal = {Exploration},
year = {2026},
doi = {10.1002/exp2.70249}
}
EUVIMED